Informed consent and tardive dyskinesia.
To determine whether a formalized informing process transmitted knowledge concerning the risks and benefits of neuroleptic medication, particularly the risk of tardive dyskinesia, to stable schizophrenic outpatients, the authors administered a multiple-choice questionnaire to 21 patients who were read a standardized information form and 27 patients who were not. The mean scores for the informed patients were significantly higher, and the differences between the two groups remained significant at 6-month follow-up. The information process had no adverse effects on frequency of psychiatric admission, noncompliance with medication, or the need for increased antipsychotic medication.
Kleinman
I
I
Department of Psychiatry, Mount Sinai Hospital, Toronto, Ont., Canada.
Schachter
D
D
Koritar
E
E
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D032882:Comprehension; D032962:Consent Forms; D030881:Disclosure; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007258:Informed Consent; D008297:Male; D008568:Memory; D028642:Persons with Psychiatric Disorders; D010353:Patient Education as Topic; D018570:Risk Assessment; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents